Novavax (NVAX) News Today $7.64 +0.04 (+0.46%) As of 02:37 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Zacks Research Comments on Novavax FY2027 EarningsNovavax, Inc. (NASDAQ:NVAX - Free Report) - Equities researchers at Zacks Research issued their FY2027 earnings per share estimates for Novavax in a research report issued on Thursday, March 20th. Zacks Research analyst S. Ganoria anticipates that the biopharmaceutical company will post earningsMarch 24 at 2:53 AM | marketbeat.comCharles Schwab Investment Management Inc. Increases Holdings in Novavax, Inc. (NASDAQ:NVAX)Charles Schwab Investment Management Inc. lifted its position in Novavax, Inc. (NASDAQ:NVAX - Free Report) by 3.0% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,365,414 shares of the biopharmaceutical company's stock after purchasing an additionaMarch 22 at 3:10 AM | marketbeat.comNovavax (NASDAQ:NVAX) Stock Price Down 6.1% - Here's WhyNovavax (NASDAQ:NVAX) Stock Price Down 6.1% - What's Next?March 19, 2025 | marketbeat.com2 Beaten-Down Stocks Near Their 52-Week Lows That Aren't Worth BuyingMarch 15, 2025 | fool.comMonaco Asset Management SAM Has $2.29 Million Stake in Novavax, Inc. (NASDAQ:NVAX)Monaco Asset Management SAM raised its position in Novavax, Inc. (NASDAQ:NVAX - Free Report) by 356.0% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 285,000 shares of the biopharmaceutical company's stock after purchasing an additional 222,500 shares duMarch 15, 2025 | marketbeat.comNovavax Appoints Margaret McGlynn To Succeed James Young As Chair Of The BoardMarch 13, 2025 | nasdaq.comUnusually active option classes on open March 13thMarch 13, 2025 | markets.businessinsider.comNovavax, Inc. (NVAX) Leerink Partners 2025 Global Healthcare Conference (Transcript)March 11, 2025 | seekingalpha.comNeed To Know: Analysts Just Made A Substantial Cut To Their Novavax, Inc. (NASDAQ:NVAX) EstimatesMarch 11, 2025 | finance.yahoo.comNovavax Announces Changes to Board of DirectorsMarch 11, 2025 | prnewswire.comNovavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from AnalystsShares of Novavax, Inc. (NASDAQ:NVAX - Get Free Report) have been assigned a consensus recommendation of "Hold" from the seven analysts that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hMarch 9, 2025 | marketbeat.comNovavax (NASDAQ:NVAX) Stock Price Up 6.7% - Here's WhyNovavax (NASDAQ:NVAX) Stock Price Up 6.7% - Still a Buy?March 8, 2025 | marketbeat.comNovavax, Inc. (NASDAQ:NVAX) Shares Bought by Oppenheimer & Co. Inc.Oppenheimer & Co. Inc. raised its holdings in Novavax, Inc. (NASDAQ:NVAX - Free Report) by 262.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 43,573 shares of the biopharmaceutical company's stock after acquirMarch 8, 2025 | marketbeat.comNovavax (NasdaqGS:NVAX) Shares Rise 11% Following Q4 2024 Earnings ImprovementMarch 7, 2025 | finance.yahoo.comB. Riley Brokers Decrease Earnings Estimates for NovavaxNovavax, Inc. (NASDAQ:NVAX - Free Report) - Stock analysts at B. Riley decreased their Q1 2025 earnings per share (EPS) estimates for shares of Novavax in a report released on Monday, March 3rd. B. Riley analyst M. Mamtani now anticipates that the biopharmaceutical company will post earnings of (March 6, 2025 | marketbeat.comSBI Securities Co. Ltd. Buys Shares of 34,485 Novavax, Inc. (NASDAQ:NVAX)SBI Securities Co. Ltd. bought a new stake in Novavax, Inc. (NASDAQ:NVAX - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 34,485 shares of the biopharmaceutical company's stock, valued at approximately $277,000March 6, 2025 | marketbeat.comNovavax (NVAX) Predicts Profitability by 2027 Despite Recent Stock DropMarch 6, 2025 | tipranks.comNovavax, Inc. (NVAX) TD Cowen 45th Annual Health Care Conference (Transcript)March 4, 2025 | seekingalpha.comWhat is Zacks Research's Forecast for Novavax Q1 Earnings?Novavax, Inc. (NASDAQ:NVAX - Free Report) - Stock analysts at Zacks Research dropped their Q1 2025 earnings per share (EPS) estimates for Novavax in a research report issued to clients and investors on Wednesday, February 26th. Zacks Research analyst S. Ganoria now forecasts that the biopharmaceuMarch 4, 2025 | marketbeat.comNovavax (NASDAQ:NVAX) Rating Increased to Hold at TD CowenTD Cowen raised shares of Novavax to a "hold" rating in a report on Thursday.March 2, 2025 | marketbeat.comNewEdge Wealth LLC Buys 70,117 Shares of Novavax, Inc. (NASDAQ:NVAX)NewEdge Wealth LLC grew its stake in shares of Novavax, Inc. (NASDAQ:NVAX - Free Report) by 70.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 170,117 shares of the biopharmaceutical company's stock aftMarch 2, 2025 | marketbeat.comNovavax, Inc. (NASDAQ:NVAX) Shares Could Be 45% Below Their Intrinsic Value EstimateMarch 1, 2025 | uk.finance.yahoo.comZacks Research Has Negative Estimate for Novavax Q4 EarningsNovavax, Inc. (NASDAQ:NVAX - Free Report) - Equities research analysts at Zacks Research reduced their Q4 2026 earnings per share (EPS) estimates for Novavax in a report issued on Wednesday, February 26th. Zacks Research analyst S. Ganoria now forecasts that the biopharmaceutical company will earMarch 1, 2025 | marketbeat.comBTIG Research Initiates Coverage on Novavax (NASDAQ:NVAX)BTIG Research began coverage on shares of Novavax in a research note on Friday. They issued a "buy" rating and a $19.00 price objective for the company.March 1, 2025 | marketbeat.comNovavax (NASDAQ:NVAX) Issues Quarterly Earnings Results, Beats Expectations By $0.24 EPSNovavax (NASDAQ:NVAX - Get Free Report) released its earnings results on Thursday. The biopharmaceutical company reported ($0.51) earnings per share for the quarter, topping analysts' consensus estimates of ($0.75) by $0.24. During the same period in the previous year, the business posted ($1.44) earnings per share.February 28, 2025 | marketbeat.comNovavax (NASDAQ:NVAX) Releases Earnings Results, Beats Expectations By $0.24 EPSNovavax (NASDAQ:NVAX - Get Free Report) released its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.51) EPS for the quarter, beating analysts' consensus estimates of ($0.75) by $0.24. During the same period in the previous year, the business earned ($1.44) earnings per share.February 28, 2025 | marketbeat.comNovavax Q4 Earnings Review: Long-Term Downsizing Plan Suggests Sell RatingFebruary 28, 2025 | seekingalpha.comNovavax Q4 Earnings Review: Long-Term Downsizing Plan Suggests Sell RatingFebruary 28, 2025 | seekingalpha.comNovavax (NASDAQ:NVAX) Stock Price Up 11.6% After Strong EarningsNovavax (NASDAQ:NVAX) Stock Price Up 11.6% on Strong EarningsFebruary 28, 2025 | marketbeat.com1 Biotech Stock to Buy in 2025, and 1 to AvoidFebruary 28, 2025 | msn.comNovavax Inc (NVAX) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Financial ...February 28, 2025 | finance.yahoo.comDecoding Novavax Inc (NVAX): A Strategic SWOT InsightFebruary 28, 2025 | gurufocus.comNovavax Lands Wall Street 'Buy' Rating After Q4 Results, Retail Bulls Eye More Upside On Sanofi PartnershipFebruary 27, 2025 | msn.comNovavax execs lay out 2025 game plan, talk ‘defining moment’ for businessFebruary 27, 2025 | bizjournals.comNovavax posts Q4 revenue beat despite 80% drop in product salesFebruary 27, 2025 | msn.comNovavax initiated with a Buy at BTIGFebruary 27, 2025 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Novavax (NVAX) and Ramsay Health Care (OtherRMSYF)February 27, 2025 | markets.businessinsider.comNovavax Inc (NVAX) Announces Participation in March Investor ConferencesFebruary 27, 2025 | gurufocus.comNovavax to Participate in Upcoming March Investor ConferencesFebruary 27, 2025 | prnewswire.comNovavax, Inc. (NVAX) Q4 2024 Earnings Call TranscriptFebruary 27, 2025 | seekingalpha.comNovavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize ValueFebruary 27, 2025 | benzinga.comNovavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize ValueFebruary 27, 2025 | benzinga.comNovavax Reports Fourth Quarter and Full Year 2024 Financial Results and Operational HighlightsFebruary 27, 2025 | investing.comNovavax, Inc. 2024 Q4 - Results - Earnings Call PresentationFebruary 27, 2025 | seekingalpha.comNovavax's quarterly loss shrinks as it ramps down spending on COVID vaccinesFebruary 27, 2025 | reuters.comNovavax Stock Is Rising. Revenue Beat Estimates.February 27, 2025 | barrons.comNovavax Reports Fourth Quarter and Full Year 2024 Financial Results and Operational HighlightsFebruary 27, 2025 | prnewswire.comNovavax Q4 2024 Earnings PreviewFebruary 26, 2025 | seekingalpha.comWhat is B. Riley's Forecast for Novavax FY2024 Earnings?Novavax, Inc. (NASDAQ:NVAX - Free Report) - B. Riley decreased their FY2024 earnings per share (EPS) estimates for shares of Novavax in a report released on Thursday, February 20th. B. Riley analyst M. Mamtani now anticipates that the biopharmaceutical company will post earnings per share of ($1.February 25, 2025 | marketbeat.comNovavax: Promising Innovations Amidst Execution and Competitive Challenges – Hold RatingFebruary 24, 2025 | tipranks.com Remove Ads Get Novavax News Delivered to You Automatically Sign up to receive the latest news and ratings for NVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address NVAX Media Mentions By Week NVAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVAX News Sentiment▼0.590.64▲Average Medical News Sentiment NVAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVAX Articles This Week▼49▲NVAX Articles Average Week Remove Ads Get Novavax News Delivered to You Automatically Sign up to receive the latest news and ratings for NVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amicus Therapeutics News Ligand Pharmaceuticals News Dynavax Technologies News BioCryst Pharmaceuticals News MannKind News Celldex Therapeutics News OPKO Health News Innoviva News Geron News Myriad Genetics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVAX) was last updated on 3/24/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredMusk’s real agenda in D.C. Companies connected to Elon’s new map of America are making major climbs in price. And on May 30, the next wav...Porter & Company | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novavax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novavax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
